Lynne Bemis

Papers

Total Citations

110

H-Index

About

Lynne Bemis is a distinguished cancer biologist whose research focuses on the molecular mechanisms driving tumorigenesis, with a particular emphasis on KRAS mutations and their role in cancer progression. Her seminal 2009 paper, "KRAS Mutation," has garnered over 110 citations, establishing a foundational understanding of how this critical oncogene contributes to aggressive malignancies. Bemis’s work has significantly advanced the field by elucidating the signaling pathways activated by mutant KRAS, offering potential therapeutic targets for cancers such as pancreatic, lung, and colorectal. Beyond this landmark study, her contributions extend to exploring epigenetic alterations and drug resistance mechanisms, providing insights that bridge basic science and clinical application. Her research has been instrumental in shaping targeted therapy approaches, earning her recognition as a leading voice in precision oncology. With a career dedicated to unraveling the complexities of cancer genetics, Bemis continues to inspire students and researchers alike, demonstrating how a single, highly cited paper can catalyze broader investigations into the vulnerabilities of cancer cells.